Advisory Services Network’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-765
Closed -$880 3605
2026
Q1
$880 Buy
+765
New +$974 ﹤0.01% 4337
2025
Q4
Sell
-765
Closed -$773 3255
2025
Q3
$773 Buy
+765
New +$835 ﹤0.01% 3986
2024
Q1
Sell
-765
Closed -$1.08K 2732
2023
Q4
$1.08K Buy
+765
New +$1.01K ﹤0.01% 3518

Other funds holding LUCD

Advisory Services Network's LUCD Position: Q2 2026 in Review

Advisory Services Network sold out of Lucid Diagnostics (LUCD) in Q2 2026, closing a stake of 765 shares — an estimated $880 sold.

Advisory Services Network first reported a position in LUCD in Q4 2023 and held it in 3 quarters. The position peaked at $1.08K in Q4 2023. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Advisory Services Network reported no remaining Lucid Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 765 Lucid Diagnostics shares in Q2 2026, an estimated $880.
  • Advisory Services Network first reported a position in Lucid Diagnostics in Q4 2023 and held it in 3 quarters.
  • Advisory Services Network's Lucid Diagnostics position peaked at $1.08K in Q4 2023.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.